Arovella Therapeutics Limited

ASX:ALA Stock Report

Market Cap: AU$180.1m

Arovella Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

ASX:ALA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
13 Sep 24SellAU$6,502,097Merchant Group Pty Ltd,Asset Management ArmCompany6,502,098AU$1.00
31 Aug 24BuyAU$987,217Merchant Funds Management Pty LtdCompany13,623,122AU$0.083
31 Jul 24SellAU$1,041,383Merchant Funds Management Pty LtdCompany11,313,335AU$0.12
30 Jun 24BuyAU$1,603,731Merchant Group Pty Ltd,Asset Management ArmCompany22,575,474AU$0.071
30 Jun 24BuyAU$518,139Merchant Funds Management Pty LtdCompany7,800,000AU$0.11
30 Apr 24BuyAU$795,944Merchant Group Pty Ltd,Asset Management ArmCompany9,472,222AU$0.084
30 Apr 24SellAU$217,074Merchant Funds Management Pty LtdCompany2,000,000AU$0.11
28 Mar 24BuyAU$14,935Thomas DuthyIndividual103,000AU$0.14
28 Mar 24BuyAU$10,000Gary PhillipsIndividual66,666AU$0.15
27 Mar 24BuyAU$31,290Michael BakerIndividual220,000AU$0.14

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of ALA?
Owner TypeNumber of SharesOwnership Percentage
Institutions117,078,22311.1%
Private Companies124,358,41311.7%
Individual Insiders169,285,48816%
General Public648,666,40561.2%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 16.5%.


Top Shareholders

Top 25 shareholders own 38.67% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
5.6%
Trust Company Funds Management Ltd.
59,369,000AU$10.1m0%0.53%
5.45%
Merchant Group Pty Ltd,Asset Management Arm
57,709,223AU$9.8m79.4%72.1%
4.81%
Mann Beef Pty Ltd
50,905,657AU$8.7m0%no data
2.62%
Matthew Buckley
27,749,415AU$4.7m0%no data
2.07%
James Hughes-Morris
21,917,196AU$3.7m0%no data
1.97%
Daniel Phillips
20,834,940AU$3.5m0%no data
1.95%
Blackburne Capital Pty Ltd
20,695,706AU$3.5m7.93%no data
1.62%
Shahen Mekertichian
17,166,666AU$2.9m9.57%no data
1.43%
Tk Cooper Holdings Pty Ltd
15,186,620AU$2.6m0%no data
1.28%
M & M Stock One Pty Ltd
13,596,581AU$2.3m21.4%no data
1.23%
Neil Delroy
13,067,222AU$2.2m26.6%no data
1.18%
Peter Cook
12,543,194AU$2.1m0%no data
1.13%
Murray James Way Pty Ltd
12,022,400AU$2.0m64.2%no data
1.07%
Naomi Hughes-Morris
11,309,868AU$1.9m0%no data
1.04%
Moovnup Pty Ltd
11,067,962AU$1.9m9.09%no data
0.98%
Clive Jones
10,390,789AU$1.8m2.47%no data
0.94%
Richard Mann
10,000,000AU$1.7m181%no data
0.62%
Michael Baker
6,567,472AU$1.1m0%no data
0.45%
Sharon Martin
4,782,485AU$813.0k0%no data
0.45%
Brendan Martin
4,782,485AU$813.0k0%no data
0.45%
Thomas Duthy
4,747,444AU$807.1k0%no data
0.083%
Fresh Start Australia Pty Ltd
883,487AU$150.2k0%no data
0.078%
Nicole van der Weerden
822,222AU$139.8k0%no data
0.074%
Gary Phillips
788,888AU$134.1k0%no data
0.074%
Gary Phillips
788,888AU$134.1k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 06:44
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Arovella Therapeutics Limited is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Nidhi SinghEdison Investment Research
Andrew GoodsallMST Financial Services Pty Limited